Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Versicans | 8 | 2014 | 44 | 1.680 |
Why?
|
| Gene Expression Regulation, Developmental | 8 | 2019 | 328 | 1.500 |
Why?
|
| Aortic Valve | 5 | 2019 | 249 | 1.440 |
Why?
|
| Heart Valves | 6 | 2016 | 171 | 1.390 |
Why?
|
| Heart Valve Diseases | 4 | 2019 | 123 | 1.220 |
Why?
|
| Heart | 10 | 2014 | 850 | 1.000 |
Why?
|
| Myocardium | 10 | 2018 | 1204 | 0.990 |
Why?
|
| Embryonic Development | 4 | 2015 | 100 | 0.970 |
Why?
|
| ADAM Proteins | 7 | 2019 | 53 | 0.930 |
Why?
|
| ADAMTS5 Protein | 3 | 2019 | 4 | 0.900 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 2015 | 36 | 0.780 |
Why?
|
| Endocardial Cushions | 2 | 2018 | 20 | 0.750 |
Why?
|
| Embryo, Mammalian | 3 | 2018 | 176 | 0.720 |
Why?
|
| Aorta | 3 | 2019 | 316 | 0.710 |
Why?
|
| Cell Lineage | 3 | 2018 | 146 | 0.690 |
Why?
|
| Lumican | 2 | 2016 | 8 | 0.690 |
Why?
|
| Aggrecans | 1 | 2019 | 13 | 0.690 |
Why?
|
| Proteoglycans | 3 | 2019 | 103 | 0.680 |
Why?
|
| Myocytes, Cardiac | 5 | 2015 | 442 | 0.670 |
Why?
|
| Extracellular Matrix Proteins | 4 | 2015 | 144 | 0.670 |
Why?
|
| Vascular Malformations | 1 | 2019 | 19 | 0.660 |
Why?
|
| Smad2 Protein | 2 | 2019 | 42 | 0.600 |
Why?
|
| Mice | 22 | 2019 | 8474 | 0.570 |
Why?
|
| Fibromodulin | 1 | 2016 | 3 | 0.560 |
Why?
|
| Animals | 30 | 2019 | 20881 | 0.510 |
Why?
|
| Keratan Sulfate | 1 | 2015 | 12 | 0.510 |
Why?
|
| Calcium-Binding Proteins | 5 | 2016 | 114 | 0.490 |
Why?
|
| Endocardium | 3 | 2015 | 101 | 0.460 |
Why?
|
| Cell Adhesion Molecules | 5 | 2007 | 199 | 0.420 |
Why?
|
| Proteolysis | 1 | 2013 | 97 | 0.420 |
Why?
|
| Collagen | 1 | 2015 | 636 | 0.400 |
Why?
|
| Immunohistochemistry | 7 | 2019 | 1174 | 0.380 |
Why?
|
| Heart Defects, Congenital | 2 | 2013 | 596 | 0.360 |
Why?
|
| Signal Transduction | 3 | 2014 | 2689 | 0.330 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 1033 | 0.290 |
Why?
|
| Lectins, C-Type | 1 | 2006 | 39 | 0.280 |
Why?
|
| Heart Ventricles | 6 | 2015 | 738 | 0.260 |
Why?
|
| Chick Embryo | 6 | 2007 | 379 | 0.260 |
Why?
|
| Extracellular Matrix | 6 | 2015 | 493 | 0.260 |
Why?
|
| Neural Crest | 3 | 2016 | 58 | 0.230 |
Why?
|
| Cadherins | 1 | 2003 | 93 | 0.220 |
Why?
|
| Protein Isoforms | 3 | 2015 | 246 | 0.210 |
Why?
|
| Mesoderm | 4 | 2011 | 231 | 0.200 |
Why?
|
| Morphogenesis | 2 | 2011 | 159 | 0.170 |
Why?
|
| Ventricular Function, Left | 2 | 2015 | 481 | 0.170 |
Why?
|
| Mice, Knockout | 6 | 2016 | 1692 | 0.170 |
Why?
|
| Sodium-Calcium Exchanger | 2 | 2009 | 69 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 3 | 2014 | 384 | 0.170 |
Why?
|
| Cell Proliferation | 3 | 2015 | 1174 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 4 | 2015 | 2791 | 0.160 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 191 | 0.160 |
Why?
|
| Matrix Metalloproteinase 9 | 3 | 2015 | 160 | 0.160 |
Why?
|
| Troponin T | 1 | 2018 | 16 | 0.160 |
Why?
|
| Models, Animal | 1 | 2019 | 252 | 0.160 |
Why?
|
| Pulmonary Valve | 1 | 2018 | 40 | 0.150 |
Why?
|
| Ventricular Remodeling | 3 | 2015 | 318 | 0.150 |
Why?
|
| Collagen Type I | 2 | 2016 | 175 | 0.150 |
Why?
|
| Myocardial Infarction | 2 | 2015 | 807 | 0.150 |
Why?
|
| Histone Deacetylase 1 | 2 | 2015 | 32 | 0.150 |
Why?
|
| Matrix Metalloproteinases | 2 | 2010 | 223 | 0.140 |
Why?
|
| Biglycan | 1 | 2016 | 2 | 0.140 |
Why?
|
| Collagen Type VI | 1 | 2016 | 5 | 0.140 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2015 | 145 | 0.140 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2016 | 7 | 0.140 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 1293 | 0.130 |
Why?
|
| Crosses, Genetic | 2 | 2013 | 60 | 0.130 |
Why?
|
| Decorin | 1 | 2015 | 8 | 0.130 |
Why?
|
| Microscopy, Confocal | 2 | 2007 | 337 | 0.130 |
Why?
|
| Cell Size | 1 | 2015 | 76 | 0.130 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 1753 | 0.130 |
Why?
|
| Solubility | 1 | 2015 | 134 | 0.130 |
Why?
|
| Hypertrophy | 1 | 2015 | 89 | 0.120 |
Why?
|
| Glycosaminoglycans | 1 | 2015 | 88 | 0.120 |
Why?
|
| Molecular Weight | 1 | 2015 | 358 | 0.120 |
Why?
|
| Fetus | 1 | 2015 | 157 | 0.120 |
Why?
|
| Animals, Newborn | 1 | 2015 | 396 | 0.120 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2015 | 116 | 0.120 |
Why?
|
| ADAMTS9 Protein | 2 | 2012 | 4 | 0.110 |
Why?
|
| Filamins | 1 | 2013 | 17 | 0.110 |
Why?
|
| Actins | 1 | 2013 | 249 | 0.100 |
Why?
|
| Chickens | 3 | 2007 | 232 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2011 | 57 | 0.100 |
Why?
|
| Models, Biological | 1 | 2015 | 981 | 0.090 |
Why?
|
| Aortic Diseases | 1 | 2012 | 113 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2009 | 682 | 0.090 |
Why?
|
| Lac Operon | 1 | 2010 | 54 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2013 | 1200 | 0.090 |
Why?
|
| Genes | 1 | 2010 | 86 | 0.090 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2009 | 26 | 0.090 |
Why?
|
| Transcription Factor AP-1 | 1 | 2009 | 61 | 0.090 |
Why?
|
| Adenoviridae | 2 | 2007 | 295 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2010 | 102 | 0.080 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2009 | 153 | 0.080 |
Why?
|
| Cardiovascular System | 1 | 2010 | 85 | 0.080 |
Why?
|
| Hyaluronic Acid | 2 | 2007 | 206 | 0.080 |
Why?
|
| Electric Stimulation Therapy | 1 | 2010 | 147 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 99 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2005 | 95 | 0.070 |
Why?
|
| Connective Tissue | 1 | 2007 | 61 | 0.070 |
Why?
|
| Blotting, Northern | 2 | 2004 | 189 | 0.070 |
Why?
|
| Fibrillar Collagens | 1 | 2007 | 49 | 0.070 |
Why?
|
| In Situ Hybridization | 2 | 2004 | 201 | 0.070 |
Why?
|
| Microinjections | 1 | 2007 | 130 | 0.070 |
Why?
|
| Cell Extracts | 1 | 2006 | 21 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 2004 | 357 | 0.070 |
Why?
|
| Body Patterning | 1 | 2006 | 44 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2007 | 161 | 0.070 |
Why?
|
| Melanocytes | 1 | 2005 | 23 | 0.060 |
Why?
|
| Binding Sites | 1 | 2007 | 631 | 0.060 |
Why?
|
| Organogenesis | 1 | 2005 | 49 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2004 | 1083 | 0.060 |
Why?
|
| Mutation | 2 | 2007 | 1213 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2004 | 1447 | 0.060 |
Why?
|
| Gene Library | 1 | 2003 | 68 | 0.060 |
Why?
|
| Sequence Alignment | 1 | 2003 | 165 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 322 | 0.050 |
Why?
|
| Phylogeny | 1 | 2003 | 197 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2009 | 753 | 0.050 |
Why?
|
| Base Sequence | 1 | 2003 | 1015 | 0.050 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2000 | 9 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2005 | 1034 | 0.050 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2000 | 46 | 0.050 |
Why?
|
| Biomarkers | 1 | 2005 | 1593 | 0.040 |
Why?
|
| Pregnancy | 2 | 2016 | 2334 | 0.040 |
Why?
|
| Cats | 2 | 2009 | 292 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2012 | 791 | 0.040 |
Why?
|
| Biomechanical Phenomena | 2 | 2012 | 368 | 0.040 |
Why?
|
| Time Factors | 1 | 2006 | 4655 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 615 | 0.040 |
Why?
|
| Humans | 6 | 2016 | 68618 | 0.040 |
Why?
|
| Fetal Heart | 2 | 2008 | 41 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 700 | 0.030 |
Why?
|
| Embryo Loss | 1 | 2016 | 17 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 65 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2016 | 50 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1664 | 0.030 |
Why?
|
| Protein Binding | 2 | 2009 | 1027 | 0.030 |
Why?
|
| Tricuspid Valve | 2 | 2005 | 42 | 0.030 |
Why?
|
| Mitral Valve | 2 | 2005 | 166 | 0.030 |
Why?
|
| Heart Septal Defects | 1 | 2014 | 27 | 0.030 |
Why?
|
| Species Specificity | 2 | 2005 | 303 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2007 | 954 | 0.030 |
Why?
|
| ADAMTS1 Protein | 1 | 2011 | 9 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 14 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2012 | 90 | 0.020 |
Why?
|
| Proteomics | 1 | 2014 | 246 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 166 | 0.020 |
Why?
|
| Rats | 2 | 2009 | 5300 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 150 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 147 | 0.020 |
Why?
|
| Receptor, ErbB-2 | 1 | 2011 | 129 | 0.020 |
Why?
|
| Elastin | 1 | 2012 | 116 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 420 | 0.020 |
Why?
|
| Female | 4 | 2016 | 38074 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 507 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2010 | 25 | 0.020 |
Why?
|
| Systole | 1 | 2010 | 149 | 0.020 |
Why?
|
| Diastole | 1 | 2010 | 161 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2009 | 71 | 0.020 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2009 | 5 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 39 | 0.020 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2009 | 27 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2009 | 93 | 0.020 |
Why?
|
| Pacemaker, Artificial | 1 | 2010 | 157 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2009 | 223 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2009 | 84 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 2010 | 153 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2009 | 235 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2009 | 250 | 0.020 |
Why?
|
| Swine | 1 | 2010 | 672 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 226 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 157 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2008 | 42 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2008 | 88 | 0.020 |
Why?
|
| Heart Rate | 1 | 2010 | 568 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 188 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1641 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2010 | 586 | 0.020 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2007 | 27 | 0.020 |
Why?
|
| Echocardiography | 1 | 2010 | 515 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 148 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 127 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 132 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 331 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 492 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 200 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2008 | 296 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 320 | 0.020 |
Why?
|
| Genotype | 1 | 2008 | 786 | 0.020 |
Why?
|
| Chordae Tendineae | 1 | 2005 | 7 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2005 | 95 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2005 | 67 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2010 | 902 | 0.020 |
Why?
|
| Heart Septum | 1 | 2005 | 84 | 0.020 |
Why?
|
| RNA Probes | 1 | 2004 | 15 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 2005 | 117 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2077 | 0.020 |
Why?
|
| Endothelium | 1 | 2004 | 98 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 189 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2004 | 231 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 2550 | 0.010 |
Why?
|
| Skin | 1 | 2007 | 451 | 0.010 |
Why?
|
| Aging | 1 | 2009 | 911 | 0.010 |
Why?
|
| Male | 3 | 2012 | 37321 | 0.010 |
Why?
|
| Cell Line | 1 | 2007 | 1752 | 0.010 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2000 | 7 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2000 | 74 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2000 | 98 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2000 | 282 | 0.010 |
Why?
|